Journal of Neuro-Oncology

, Volume 29, Issue 3, pp 197–205 | Cite as

Epidemiology and etiology of intracranial meningiomas: A review

  • Melissa Bondy
  • B. Lee Ligon


The frequency of meningiomas has been the topic of relatively few reports. Hospital-based brain tumor series indicate that the incidence is approximately 20% of all intracranial tumors; population-based studies indicate an overall incidence of 2.3/100,000. Although intracranial tumors as a whole show a higher prevalence in males than in females, meningiomas have a 2: 1 female-to-male ratio. Between Caucasians and Africans, African-Americans, and Asians, certain differences also have been noted. Meningiomas in children are rare and differ from those in adults and other childhood tumors; they are even more rare in infants. Several features indicating etiologic factors have been identified, among which are ionizing radiation, head injury, hormones, and other receptor binding sites, genetic factors, and viruses. The most common source of exposure of the head to ionizing radiation is dental radiographic examination. Since 1922, head trauma has been considered a possible risk factor, but recent large studies do not support this link. Several factors have prompted studies of estrogens and progestogens as risk factors for meningiomas. Other studies have sought to determine if certain individuals have an inherited predisposition for developing a meningioma and/or if viruses, which may act alone or with other mutagens, figure into the formation of a meningioma. The most promising studies are those of cytogenetics, and future elucidation of factors associated with the loss of one copy of chromosome 22, another phenomenon that has been identified in meningiomas, may lead to screening tests and gene therapy.

Key words

meningiomas epidemiology etiology radiation progesterone trauma 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Watkins D, Rouleau GA: Genetics, prognosis and therapy of central nervous system tumors. Cancer Detection and Prevention 18: 139–144, 1994Google Scholar
  2. 2.
    Preston-Martin S: Descriptive epidemiology of primary tumors of the brain, cranial nerves and cranial meninges in Los Angeles county. Neuroepidemiology 8: 283–295, 1989Google Scholar
  3. 3.
    Longstreth WT, Dennis LK, McGuire VM, Drangsholt MT, Koepsell TD: Epidemiology of intracranial meningioma. Cancer 72: 639–648, 1993Google Scholar
  4. 4.
    Plater F: Observationum in hominis affectibus plerisque, corpori et anomo, functionum laesione, dolore, aliave molestia et vitio incommodantibus, libri tres. Basileae, Impensis Ludovici Konig, 1614Google Scholar
  5. 5.
    Louis A: Mémoire sur les tumeurs fongueuses de la dremere. Mémoires Acad R Chir Paris 19: 101, 1774Google Scholar
  6. 6.
    Bright R: Reports of medical cases, symptoms and morbid anatoma. In: Bright R (ed) Diseases of the Brain and Nervous System. London, Longman vol II, part I, 1831, p 342Google Scholar
  7. 7.
    Cruveilhier J: L'Anatomie pathologique du corps humain. Paris, JB Baillière, 1934, p 1829Google Scholar
  8. 8.
    Cushing H: The meningiomas (dural endotheliomas): Their source, and favored seats of origin. (Cavendish Lecture) Brain 45: 282–316, 1922Google Scholar
  9. 9.
    DeMonte F, Al-Mefty O: Meningiomas. In: Kaye AH, Laws ER Jr (eds) Brain Tumors: An Encyclopedic Approach. Churchill Livingstone, New York, 1995, pp 675–704Google Scholar
  10. 10.
    Al-Rodhan NRF, Laws ER: Meningioma: A historical study of the tumor and its surgical management. Neurosurgery 26: 832, 1990Google Scholar
  11. 11.
    Black PMcL: Meningiomas. Neurosurg 32: 643–657, 1993Google Scholar
  12. 12.
    Rachlin JR, Rosenblum ML: Etiology and biology of meningiomas. In: Al-Mefty O (ed) Meningiomas. NY, Raven Press, Ltd, New York, 1991, pp 27–35Google Scholar
  13. 13.
    Cushing H: Intracranial tumors. Notes upon a series of two thousand verified cases with surgical mortality percentages pertaining thereto. Springfield, Illinois: Charles C. Thomaas, 1932Google Scholar
  14. 14.
    Zimmerman HM: Brain tumors: their incidence and classification in man and their experimental production. Ann N Y Acad Sci 159: 337–359, 1969Google Scholar
  15. 15.
    Percy AK, Elveback LR, Okazaki H, Kurland LT: Neoplasms of the central nervous system: epidemiologic considerations. Neurology 22: 40–48, 1972Google Scholar
  16. 16.
    Rohringer M, Sutherland GR, Louw DF, Sima AAF: Incidence and clinicopathological features of meningiomas. J Neurosurg 71: 665–672, 1989Google Scholar
  17. 17.
    Sutherland GR, Florell R, Louw D, et al.: Epidemiology of primary intracranial neoplasms in Manitoba, Canada. Canadian J Neurol Sci 14: 586–592, 1987Google Scholar
  18. 18.
    Preston-Martin S, Henderson BE, Peters JM: Descriptive epidemiology of central nervous system neoplasms in Los AngelesCounty. Annals NY Acad Sci 381: 202–208,1982Google Scholar
  19. 19.
    Kurland LT, Schoenberg BS, Annegers JF, et al.: The incidence of primary intracranial neoplasms in Rochester, Minnesota, 1935–1977. Ann NY Acad Sci 381: 6–16,1982Google Scholar
  20. 20.
    Walker AE, Robins M, Weinfeld, FD: Epidemiology of brain tumors: The national survey of intracranial neoplasms. Neurology 35:219–226,1985Google Scholar
  21. 21.
    Rohringer M, Sutherland GR, Louw DF, Sima AAF: Incidence and clinicopathological features of meningioma. J Neurosurg 71: 665–672,1989Google Scholar
  22. 22.
    Helseth A, Mork SJ, Johansen A, Treth S: Neoplasms of the central nervous system in Norway: IV A population-based epidemiological study of meningiomas. APMIS 97:646–654, 1989Google Scholar
  23. 23.
    Staneczek W. Jänisch W: Epidemiologic data on meningiomas in East Germany 1961–1986: Incidence, localization, age and sex distribution. Clin Neuropathol 11:135–141,1992Google Scholar
  24. 24.
    Fan KJ, Pezeshkpour GH: Ethnic distribution of primary central nervous system tumors in Washington, DC, 1971–1985. J Natl Med Assoc 84: 858–863,1992Google Scholar
  25. 25.
    Heshmat MY, Kovi J, Simpson C, Kennedy J, Fan KJ: Neoplasms of the central nervous system. Cancer 38: 2135–2142, 1976Google Scholar
  26. 26.
    Preston-Martin S, Staples M, Farrugia H, Giles G: Primary tumors of the brain, cranial nerves and cranial meninges in Victoria, Australia, 1982–1990: Patterns of incidence and survival. Neuroepidemiology 12: 270–279,1993Google Scholar
  27. 27.
    Sakaki S, Nakagawa K, Kimura H, Ohue S: Intracranial meningiomas in infancy. Surg Neuro 128: 51,1987Google Scholar
  28. 28.
    Molleston MC, Modan CJ, Roth KA, Rich KM: Infantile meningioma. Pediatr Neurosurg (Switz) 21:195–200,1994.Google Scholar
  29. 29.
    Mann I, Yates PC, Ainslie JP: Unusual case of double primary orbital tumour. Br J Ophthalmo1 37: 758–762,1953Google Scholar
  30. 30.
    Ron E, Modan B, Boice JD, Alfandary E, Stovall M, Chetrit A, et al.: Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319:1033–1039,1988Google Scholar
  31. 31.
    Modan B, Baidatz D, Mart H, Steinitz R, Levin SG: Radiation-induced head and neck tumours. Lancet 1: 277–279, 1974Google Scholar
  32. 32.
    Preston-Martin S, White SC: Brain and salivary gland tumors related to prior dental radiography: implications for current practice. J Am Dent Assoc 120:151–158,1990Google Scholar
  33. 33.
    Richards AG, Colquitt WN: Reduction in dental x-ray exposures during the past 60 years. J Am Dent Assoc 103: 713–718, 1981Google Scholar
  34. 34.
    Johnson DW, Goetz WA: Patient exposure trends in medical and dental radiography. Health Phys 50:107–116,1986Google Scholar
  35. 35.
    Underhill TE, Kimura K, Chilvarquer I, McDavid WD, et al.: Radiobiologic risk estimation from dental radiology: Part II. Cancer incidence and fatality. Oral Surg Oral Med Oral Pathol 66: 261–267,1988Google Scholar
  36. 36.
    Nolan WE: Radiation hazards to the patient from oral roentgenography. J Am Dent Assoc 47: 681–684,1953Google Scholar
  37. 37.
    Preston-Martin S, Thomas DC, White SC, Cohen D: Prior exposure to medical and dental x-rays related to tumors of the parotid gland. J Natl Cancer Inst 80: 943–949,1988Google Scholar
  38. 38.
    White SC, Rose TC: Absorbed bone marrow dose in certain dental radiographic techniques. J Am Dent Assoc 98: 553–558, 1979Google Scholar
  39. 39.
    White SC: 1992 assessment of radiation risk from dental radiography. Dentomaxillofac Radiol 21:118–126,1992Google Scholar
  40. 40.
    Gibbs SJ, Pujol A Jr, Chen TS, James A: Patient risk from intraoral dental radiography. Dentomaxillofac Radiol 17: 15–23,1988Google Scholar
  41. 41.
    Gibbs SJ, Pujol A, McDavid WD, Welander U, Tonje G: Patient risk from rotational panoramic radiography. Dentomaxillofac Radiol 17: 25–32,1988Google Scholar
  42. 42.
    Preston-Martin S, Paganini-Hill A, Henderson BE, Pike MC, Wood C: Case-control study of intracranial meningiomas in women in Los Angeles County, California. J Natl Cancer Inst 65: 67–66,1980Google Scholar
  43. 43.
    Preston-Martin S, Paganini-Hill A, Henderson BE, Pike MC, Wood C: Case-control study of intracranial meningiomas in men in Los Angeles County, California. J Natl Cancer Inst 70: 863–866,1983Google Scholar
  44. 44.
    Rachlin JR, Rosenblum ML: Etiology and biology of meningiomas. In: Al Mefty O (ed) Meningiomas. Raven, New York 1991, pp 27–35Google Scholar
  45. 45.
    Harrison MJ Wolfe DE, Lau TS, Mitnick RJ, Sachdev VP: Radiation-induced meningiomas: Experience at the Mount Sinai Hospital and review of the literature. J Neurosurg 75: 564–574,1991Google Scholar
  46. 46.
    Bernstein M, Laperriere N: Radiation-induced tumors of the nervous system. In: Gutin PH, Leibel SA, Sheline GE, (eds) Radiation Injury to the Nervous System. New York: Raven Press 1991, pp 455–472Google Scholar
  47. 47.
    MacKee, Wilson CB: Meningiomas induced by high-dose cranial irradiation. J Neurosurg 29: 28–31,1993Google Scholar
  48. 48.
    Soffer D, Pittaluga S, Feiner M, Beller AJ: Intracranial meningiomas following low-dose irradiation to the head. J Neurosurg 59:1048–1053,1983Google Scholar
  49. 49.
    Rubinstein AB, Shalit MN, Cohen ML, Zandbank U, Reichenthal E: Radiation-induced cerebral meningioma: a recognizable entity. J Neurosurg 61: 966–971,1984Google Scholar
  50. 50.
    Cushing H, Eisenhardt L: Meningiomas: Their classification, regional behavior, life history, and surgical end results. Springfield, ILL: Charles C. Thomas, 1938Google Scholar
  51. 51.
    Parker HL, Kernohan JW: The relation of injury and glioma of the brain. JAMA 97: 535–539,1931Google Scholar
  52. 52.
    Choi NW, Schuman LM, Gullen WH: Epidemiology of primary central nervous system neoplasms II. Case-control study. Am J Epidemiology 91: 467–485,1970Google Scholar
  53. 53.
    Annegers JF, Laws ER Jr., Kurland LT, Grabow JD: Head trauma and subsequent brain tumors. Neurosurgery 4: 203–206, 1979Google Scholar
  54. 54.
    Berleur M-P, Cordier S: The role of chemical, physical, or viral exposures and health factors in neurocarcinogenesis: implications for epidemiologic studies of brain tumors. Cancer Causes and Control 6: 240–256,1995Google Scholar
  55. 55.
    Smith FP, Slavik M, MacDonald JS: Association of breast cancer with meningioma: report of two cases and review of the literature. Cancer 42:1992–1994,1978Google Scholar
  56. 56.
    Mehta D, Khatib R, Patel S: Carcinoma of the breast and meningioma: association and management. Cancer 51: 1937–1940,1983Google Scholar
  57. 57.
    Michelsen JJ, New PFJ: Brain tumour and pregnancy. J Neurol Neurosurg Psychiatry 32: 305–307,1969Google Scholar
  58. 58.
    Roelvink NCA, Kamphorst W, van Alphen HAM, Rao BR: Pregnancy-related primary brain and spinal tumors. Arch Neurol 44: 209–215,1987Google Scholar
  59. 59.
    Schlehofer B, Blettner M, Wahrendorf J: Association between brain tumors and menopausal status. J Natl Cancer Inst 84:1346–1349,1992Google Scholar
  60. 60.
    Donnell MS, Meyer GA, Donegan WL: Estrogen-receptor protein in intracranial meningiomas. J Neurosurg 50: 499–502, 1979Google Scholar
  61. 61.
    Blankenstein MA, Blaauw G, Lamberts SWJ, Mulder E: Presence of progesterone receptors and absence of oestrogen receptors in human intracranial meningioma cytosols. Eur J Cancer 19: 365–370,1983Google Scholar
  62. 62.
    Blankenstein MA, Berns PMJJ, Blaauw G, Mulder E, Thijssen JHH: Search for estrogen receptors in human meningioma tissue sections with a monoclonal antibody against the human estrogen receptor. Cancer Res 46: 4268–4270,1986Google Scholar
  63. 63.
    Schrell UMH, Adams EF, Fahlbusch R, et al: Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy. J Neurosurg 73: 743–749,1990Google Scholar
  64. 64.
    Maxwell M, Galanopoulos T, Neville-Golden J, et al.: Expression of androgen and progesterone receptors in primary human meningiomas. J Neurosurg 78:456–462,1993Google Scholar
  65. 65.
    Gabes S, Berkel J: Meta-analysis of progestin and estrogen receptors in human meningiomas. Neuroepidem 11: 255–260, 1992Google Scholar
  66. 66.
    Carroll RS, Glowacka D, Dashner K, Black PM: Progesterone receptor expression in meningiomas. Cancer Res 53: 1312–1316,1993Google Scholar
  67. 67.
    Grunberg SM, Weiss MH, Spitz IM, Ahmadi J, Sadun A, Russell CA, et al.: Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg 74: 861,1991Google Scholar
  68. 68.
    Bickerstaff ER, Small JM, Guest iA: The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry 21: 89–91,1958Google Scholar
  69. 69.
    Schöenberg BS, Christine BW, Whisnant JP: Nervous system neoplasms and primary malignancy of other sites. The unique association between meningiomas and breast cancer. Neurology 25: 705–712,1975Google Scholar
  70. 70.
    Helseth A, Sverre JM, Glattre E: neoplasms of the central nervous system in Norway, V: meningioma and cancer of other sites: an analysis of the occurrence of multiple primary neoplasms in meningioma patients in Norway from 1955 through 1986. APDMIS 97:738–744,1989Google Scholar
  71. 71.
    Adami HO, Bergkvist L, Krusemo U, Persson I: Breast cancer as a risk factor for other primary malignant diseases: a nationwide cohort study. J Natl Cancer Inst 73: 1049–1055, 1984Google Scholar
  72. 72.
    Jacobs DH, Holmes FF, McFarlane MJ: Meningiomas are not significantly associated with breast cancer. Arch Neurol 49:753–756,1992Google Scholar
  73. 73.
    Weiss AF, Portmann R, Fischer H, et al.: Simian virus 40-related antigens in three human meningiomas with defined chromosome loss. Proc Natl Acad Sci USA 72:609–613,1975Google Scholar
  74. 74.
    Fiori, M, Di Mayorca G: Occurrence of BK virus DNA in DNA obtained from certain human tumors Proc Natl Acad Sci USA 73: 4662–4666,1976Google Scholar
  75. 75.
    Ibelgaufts H, Jones KW: Papovavirus related RNA sequences in human neurogenic tumors. Acta Neuropathologica (Berlin) 56:118–122,1982Google Scholar
  76. 76.
    Barbanti-Brodano G, Silini E, Mottes M, et al.: DNA probes to evaluate the possible association of papovaviruses with human tumors. In: Gallo RC et al. (eds) Monoclonals and DNA Probes in Diagnostic and Preventive Medicine. Raven Press, New York, 1987, pp 147–155Google Scholar
  77. 77.
    Joynt RJ, Perret CE: Meningiomas in a mother and daughter. Cases without evidence of neurofibromatosis. Neurology 11:164–165,1961Google Scholar
  78. 78.
    Sahar A: Familial occurrence of meningiomas. J Neurosurg 23:444–449,1965Google Scholar
  79. 79.
    Memon MY: Multiple and familial meningiomas without evidence of neurofibromatosis. Neurosurg 7: 262–264,1980Google Scholar
  80. 80.
    Sedzimir CB, Frazer AK, Roberts JR: Cranial and spinal meningiomas in a pair of identical twin boys. J Neurol Neurosurg Psychiatry 36: 368–376,1973Google Scholar
  81. 81.
    Collins VP, Nordenskjold M, Dumanski JP: The molecular genetics of meningiomas. Brain Pathol 1: 19–24,1990Google Scholar
  82. 82.
    Seizinger BR, de la Monte S, Atkins L, Gusella JF, Martuza RL: Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci USA 84:5419–5423,1987Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Melissa Bondy
    • 1
  • B. Lee Ligon
    • 2
  1. 1.Department of EpidemiologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA
  2. 2.Department of NeurosurgeryThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations